Obama-Era Contract, Past Track Record Lands McKesson COVID-19 Vaccine Distribution Deal
Executive Summary
The previous administration’s forethought may have given the Trump team a leg up in vaccine distribution. McKesson’s experience as a central distributor for the Vaccines for Children’s program, H1N1 and its role in seasonal flu vaccine distribution should make it well positioned to handle the COVID-19 effort in the US, experts said.
You may also be interested in...
McKesson Tapped For COVID-19 Vaccine Kits To Meet 1 October Distribution Goal
US HHS turns to COVID-19 vaccine distributor to assemble vaccine administration kits, citing revised vaccine delivery schedule.
COVID-19 Vaccines: US Distribution Plans Include ‘Data Lake’ For Centralized Tracking
Most vaccines will be distributed centrally by McKesson, but those with ultra-cold storage requirements will be shipped directly from the manufacturer to the vaccination site. Data exchange system will enable public and private databases to talk to each other and help ensure individuals receive timely revaccination with a second dose of the same vaccine regardless of location.
CDC Bets Vaccine Stability Conditions Will Change, Urges Against Freezer Purchases
Even as Pfizer and Moderna says their vaccines would need to be stored at very low temperatures, CDC official urges delay on equipment acquisition.